Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
Quick Stats
Mar 30, 202660.0
AI Score
HOLD0.77
Volume Ratio
May 11, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
DNTH Stock Summary
Last updated Mar 30, 2026
DNTH is currently trading at $79.45, positioned above its 200-day moving average of $38.9, indicating a long-term uptrend. The stock has a 52-week range of $13.365 to $88.0202.
Technical Analysis: The 50-day moving average stands at $60.94, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 62.448, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.063, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates DNTH at 60.0/100 with a HOLD recommendation.
DNTH (Dianthus Therapeutics, Inc. Common Stock) Indicators
Last updated Mar 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 62.448 |
| CMF (20) | -0.063 |
| ROC (10) | 0.981 |
| ADX (14) | 39.54 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 6.192 |
| AROONOSC (14) | -57.143 |
| WILLAMS %R (14) | -73.922 |
| MFI (14) | 48.117 |
DNTH Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DNTH Price vs Max Options Open Interest
DNTH Max Change In Options Open Interest
DNTH Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNTH Daily Out of Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNTH Daily In the Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNTH Most Active Options by Volume(near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Dianthus Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
DNTH Moving Averages Analysis
Dianthus Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Mar 30, 2026
Dianthus Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Mar 30, 2026
DNTH (Dianthus Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 79.6 |
| 20 | 76.41 |
| 30 | 68.17 |
| 50 | 60.94 |
| 100 | 50.93 |
| 200 | 38.9 |
DNTH Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 4.3 billion |
| Earnings/Share ($) | -4.2 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.6543 |
| EPS Estimate Next Year ($) | -5.1143 |
| WallStreet Target Price ($) | 127.75 |
| Most Recent Quarter |